About: Genset Corporation     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FGenset_Corporation&invfp=IFP_OFF&sas=SAME_AS_OFF

Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president. Genset was listed on the NASDAQ and the Paris Bourse (now NYSE Euronext) in 1996. Genset rapidly became the European flagship company in the field of genomics and became the second largest biotechnology company in Europe in 1999. At that time, the company reported identifiable assets of EUR 80.9 million and had subsidiaries in the United States, Japan, Singapore, and Australia. Genset was a pioneer in private human genome research. In 1994, Genset started the first large scale program to analyze the regulatory sequences of the human genome and in 1997 also initiated the construction of a map of single nucleotide polymorphisms as a tool to accelerate the discovery of genes a

AttributesValues
rdf:type
rdfs:label
  • Genset Corporation (en)
  • Genset (fr)
rdfs:comment
  • Genset est une entreprise créée en 1989 à Paris, en France, par Pascal Brandys, son premier président, et , qui fut cotée au NASDAQ et à la bourse de Paris à partir de 1996, avant d'être acquise en 2002 par le laboratoire suisse Serono puis intégré dans le groupe Merck. Genset a le statut de marque commerciale de la société Lyonnaise Merck Biodeveloppement. (fr)
  • Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president. Genset was listed on the NASDAQ and the Paris Bourse (now NYSE Euronext) in 1996. Genset rapidly became the European flagship company in the field of genomics and became the second largest biotechnology company in Europe in 1999. At that time, the company reported identifiable assets of EUR 80.9 million and had subsidiaries in the United States, Japan, Singapore, and Australia. Genset was a pioneer in private human genome research. In 1994, Genset started the first large scale program to analyze the regulatory sequences of the human genome and in 1997 also initiated the construction of a map of single nucleotide polymorphisms as a tool to accelerate the discovery of genes a (en)
foaf:name
  • Genset (en)
name
  • Genset (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
founded
hq location
industry
successor
has abstract
  • Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president. Genset was listed on the NASDAQ and the Paris Bourse (now NYSE Euronext) in 1996. Genset rapidly became the European flagship company in the field of genomics and became the second largest biotechnology company in Europe in 1999. At that time, the company reported identifiable assets of EUR 80.9 million and had subsidiaries in the United States, Japan, Singapore, and Australia. Genset was a pioneer in private human genome research. In 1994, Genset started the first large scale program to analyze the regulatory sequences of the human genome and in 1997 also initiated the construction of a map of single nucleotide polymorphisms as a tool to accelerate the discovery of genes associated with diseases. The company also created the business model of pharmacogenomics and started the first pharmacogenomics research program in the world in collaboration with Abbott Laboratories in 1997. After 2000 Genset changed its strategy to focus on drug development, leading to the departure of its president and other founders. The strategy shift proved unsuccessful and Genset was acquired by Serono of Switzerland in 2002, now part of Merck Serono. In 2006, Merck launched a takeover bid for Serono. (en)
  • Genset est une entreprise créée en 1989 à Paris, en France, par Pascal Brandys, son premier président, et , qui fut cotée au NASDAQ et à la bourse de Paris à partir de 1996, avant d'être acquise en 2002 par le laboratoire suisse Serono puis intégré dans le groupe Merck. Genset a le statut de marque commerciale de la société Lyonnaise Merck Biodeveloppement. (fr)
prov:wasDerivedFrom
page length (characters) of wiki page
founding year
headquarter
industry
successor
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software